Rhythm Biosciences Limited (RHY.AX)
AUD 0.08
(-3.53%)
AUD 0.08
(-3.53%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1.69 Million | 3.09 Million | 2.42 Million | 1.1 Million | 100 Thousand | 1.02 Million |
| Cost of Revenue | 3.04 Million | 189.37 Thousand | 101.48 Thousand | 146.64 Thousand | 141.28 Thousand | 65.36 Thousand |
| Gross Profit | -1.35 Million | 2.9 Million | 2.32 Million | 961.85 Thousand | -41.28 Thousand | 962.25 Thousand |
| Operating Expenses | 5.34 Million | 11.54 Million | 11.24 Million | 7.73 Million | 4.16 Million | 3.71 Million |
| Selling, General and Administrative Expenses | 3 Million | 7.5 Million | 5.89 Million | 3.02 Million | 2.03 Million | 2.58 Million |
| Research and Development Expenses | 2.34 Million | 3.64 Million | 5.15 Million | 4.55 Million | 1.93 Million | 980.28 Thousand |
| Other Expenses | - | 3.09 Million | 191.55 Thousand | 150.37 Thousand | 182.84 Thousand | 154.33 Thousand |
| Cost and Expenses | 8.39 Million | 11.54 Million | 11.24 Million | 7.73 Million | 4.16 Million | 3.71 Million |
| Operating Income | -6.7 Million | -11.54 Million | -11.24 Million | -6.61 Million | -4.01 Million | -3.71 Million |
| Interest Expense | 3143.00 | - | 24.96 Thousand | 396.00 | 7796.00 | - |
| Income Tax Expense | -1.69 Million | -228.27 Thousand | -2.47 Million | 1.1 Million | 107.79 Thousand | -1.16 Million |
| Earnings before Tax | -8.54 Million | -8.21 Million | -8.79 Million | -6.61 Million | -4.02 Million | -2.54 Million |
| Net Income | -6.85 Million | -8.21 Million | -6.31 Million | -7.72 Million | -4.13 Million | -1.37 Million |
| Earnings Per Share Basic | -0.03 | -0.04 | -0.03 | -0.04 | -0.04 | -0.01 |
| Earnings Per Share Diluted | -0.03 | -0.04 | -0.03 | -0.04 | -0.04 | -0.01 |
| Weighted Average Shares Outstanding | 228.29 Million | 221.54 Million | 214.44 Million | 189.94 Million | 117.92 Million | 117.92 Million |
| Weighted Average Shares Outstanding (Diluted) | 228.29 Million | 221.54 Million | 214.44 Million | 189.94 Million | 117.92 Million | 117.92 Million |
| Gross Margin | -0.80 | 0.94 | 0.96 | 0.87 | -0.41 | 0.94 |
| EBIT Margin | -4.02 | -3.67 | -4.59 | -5.83 | -38.74 | -3.55 |
| Profit Margin | -4.06 | -2.65 | -2.60 | -6.97 | -41.31 | -1.34 |
| EBITDA | -6.79 Million | -11.1 Million | -11.1 Million | -6.46 Million | -3.87 Million | -2.6 Million |
| Earnings Before Tax Margin | -3.97 | -3.73 | -4.63 | -5.96 | -40.15 | -3.62 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | 2.42 Million | 1.69 Million | 3.09 Million | 374.89 Thousand | 2.72 Million |
| Cost of Revenue | 198.66 Thousand | 1.21 Million | 102.58 Thousand | 189.37 Thousand | 96.18 Thousand | 93.19 Thousand |
| Gross Profit | -198.66 Thousand | 1.21 Million | 1.58 Million | 2.9 Million | 278.71 Thousand | 2.62 Million |
| Operating Expenses | 8.39 Million | 2.68 Million | 5.71 Million | 11.54 Million | 4.93 Million | 6.41 Million |
| Selling, General and Administrative Expenses | - | 1.54 Million | 1.45 Million | - | 3.5 Million | 4.19 Million |
| Research and Development Expenses | - | 1.13 Million | 1.21 Million | - | 1.42 Million | 2.22 Million |
| Other Expenses | -3.04 Million | - | -3.04 Million | 3.09 Million | - | - |
| Cost and Expenses | 8.59 Million | 3.89 Million | 5.81 Million | 11.54 Million | 5.03 Million | 6.5 Million |
| Operating Income | -8.59 Million | -3.89 Million | -5.81 Million | -11.54 Million | -5.03 Million | -6.5 Million |
| Interest Expense | 3143.00 | 3143.00 | - | - | - | - |
| Income Tax Expense | -1.69 Million | -3.00 | -1.69 Million | -228.27 Thousand | -374.6 Thousand | -2.7 Million |
| Earnings before Tax | -8.54 Million | -2.76 Million | -5.78 Million | -8.21 Million | -4.91 Million | -6.38 Million |
| Net Income | -6.85 Million | -2.76 Million | -4.09 Million | -8.21 Million | -4.53 Million | -3.67 Million |
| Earnings Per Share Basic | - | -0.01 | -0.02 | - | -0.02 | -0.02 |
| Earnings Per Share Diluted | - | -0.01 | -0.02 | - | -0.02 | -0.02 |
| Weighted Average Shares Outstanding | 228.29 Million | 235.44 Million | 225.88 Million | 221.54 Million | 221.92 Million | 221.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 228.29 Million | 235.43 Million | 225.88 Million | 221.54 Million | 221.92 Million | 221.07 Million |
| Gross Margin | - | 0.50 | 0.94 | 0.94 | 0.74 | 0.97 |
| EBIT Margin | - | -1.14 | -3.38 | - | -13.17 | -2.36 |
| Profit Margin | - | -1.14 | -2.42 | -2.65 | -12.11 | -1.35 |
| EBITDA | - | -2.76 Million | -5.71 Million | - | -4.93 Million | -6.41 Million |
| Earnings Before Tax Margin | - | -1.61 | -3.44 | -3.73 | -13.42 | -2.39 |
PYRAMID
SMAG
GIANLIFE
CPS
002184
GNL